Despite Regulatory Win, Call Writers Gamble on Limited Upside for Affymetrix
Call traders have converged on Affymetrix, Inc. (AFFX - 6.20) today, after the Food & Drug Administration (FDA) approved the use of its new gene expression agents with its genetic analysis tools...( Read More )
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here